[Safety and immunogenicity of split vaccines of influenza viruses].

Objective: To evaluate the safety and immunogenicity of influenza split vaccine.

Methods: According to the criteria of No.2002SL0043, instruction of application for new drug in clinical trial issued by the State Food and Drug Administration, 876 healthy persons were divided at random into vaccine group and control group.